FDARecalled Nov 27, 2024 · #D-0053-2025
Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Balti...
Hazard
Class II — temporary health risk
Be the first to hear about future recalls.
Add the things you own to a watchlist. We’ll alert you the moment one matches.
Get started, freeDescription
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor Classification: Class II Distribution: Product was distributed to 30 wholesalers/distributors who may have further distributed the product nationwide.
Product details
- Product
- Ramipril Capsules USP 5 mg, a) 90 count (NDC 68180-590-09), b) 100 count NDC 68180-590-01), and c) 500 count (NDC 68180-590-02) bottles, Rx only, Manufactured for Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by Lupin Limited, Goa, India
- Type
- Drugs
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Model numbers
- 68180-590-09, 68180-590-01, 68180-590-02, GA00955
- UPCs
- —